These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2020-006118-19 An Open-Label Phase 2 Study of Surufatinib in Patients with Neuroendocrine Tumours in Europe 2024-09-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2021-003602-41 AN OPEN-LABEL, MULTICENTER PHASE 1/2 STUDY OF SURUFATINIB IN COMBINATION WITH GEMCITABINE IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS 2023-04-25 bad-data